199 related articles for article (PubMed ID: 12764397)
21. Triggering of acute cardiovascular disease and potential preventive strategies.
Tofler GH; Muller JE
Circulation; 2006 Oct; 114(17):1863-72. PubMed ID: 17060396
[No Abstract] [Full Text] [Related]
22. LIFE and SCOPE: what guidance do they offer alongside ALLHAT and ANBP2?
Nicholls MG
J Hum Hypertens; 2004 May; 18(5):295-300. PubMed ID: 14739907
[No Abstract] [Full Text] [Related]
23. [Commentary on the ALLHAT study. Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial].
Wehling M
Dtsch Med Wochenschr; 2003 May; 128(22):1252. PubMed ID: 12772085
[No Abstract] [Full Text] [Related]
24. Role of diuretics in the prevention of heart failure: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.
Davis BR; Piller LB; Cutler JA; Furberg C; Dunn K; Franklin S; Goff D; Leenen F; Mohiuddin S; Papademetriou V; Proschan M; Ellsworth A; Golden J; Colon P; Crow R;
Circulation; 2006 May; 113(18):2201-10. PubMed ID: 16651474
[TBL] [Abstract][Full Text] [Related]
25. ALLHAT in perspective: implications to clinical practice and clinical trials.
Yusoff K
Med J Malaysia; 2005 Jun; 60(2):239-45. PubMed ID: 16114170
[TBL] [Abstract][Full Text] [Related]
26. Predictors of adherence with antihypertensive and lipid-lowering therapy.
Chapman RH; Benner JS; Petrilla AA; Tierce JC; Collins SR; Battleman DS; Schwartz JS
Arch Intern Med; 2005 May; 165(10):1147-52. PubMed ID: 15911728
[TBL] [Abstract][Full Text] [Related]
27. ALLHAT: what has it taught us so far?
Leenen FH
CMAJ; 2004 Sep; 171(7):719-20. PubMed ID: 15451829
[No Abstract] [Full Text] [Related]
28. Blood pressure lowering, not vascular mechanism of action, is the primary determinant of clinical outcome.
Leenen FH
Can J Cardiol; 2004 Aug; 20 Suppl B():77B-82B. PubMed ID: 15309209
[TBL] [Abstract][Full Text] [Related]
29. Characteristics and lipid distribution of a large, high-risk, hypertensive population: the lipid-lowering component of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Papademetriou V; Piller LB; Ford CE; Gordon D; Hartney TJ; Geraci TS; Reisin E; Sumner BM; Wong ND; Nwachuku C; Narayan P; Haywood J; Habib G;
J Clin Hypertens (Greenwich); 2003; 5(6):377-84. PubMed ID: 14688492
[TBL] [Abstract][Full Text] [Related]
30. ALLHAT and ANBP2: what have we learned from recent mega-trials?
Sander GE; Giles TD
Am J Geriatr Cardiol; 2003; 12(4):267-71. PubMed ID: 12888711
[No Abstract] [Full Text] [Related]
31. ALLHAT findings revisited in the context of subsequent analyses, other trials, and meta-analyses.
Onuigbo MA
Arch Intern Med; 2009 Oct; 169(19):1810; author reply 1810-1. PubMed ID: 19858442
[No Abstract] [Full Text] [Related]
32. New-onset diabetes and antihypertensive therapy: comments on ALLHAT trial.
Sierra C; Ruilope LM
J Renin Angiotensin Aldosterone Syst; 2003 Sep; 4(3):169-70. PubMed ID: 14608521
[TBL] [Abstract][Full Text] [Related]
33. Trends in antihypertensive and lipid-lowering therapy in subjects with type II diabetes: clinical effectiveness or clinical discretion?
Gulliford MC; Charlton J; Latinovic R
J Hum Hypertens; 2005 Feb; 19(2):111-7. PubMed ID: 15361893
[TBL] [Abstract][Full Text] [Related]
34. The clinical relevance of pharmacological blood pressure lowering mechanisms.
Lonn E
Can J Cardiol; 2004 Aug; 20 Suppl B():83B-88B. PubMed ID: 15309210
[TBL] [Abstract][Full Text] [Related]
35. Coronary revascularization and aggressive lipid lowering.
Pershad A; Kratzer S; Cooper A
J Invasive Cardiol; 1999 Feb; 11(2):87-9. PubMed ID: 10745488
[No Abstract] [Full Text] [Related]
36. [Statines for all or individualized lipid lowering therapy?].
Parhofer K
MMW Fortschr Med; 2009 Apr; 151(14):100, 102-4; quiz 105. PubMed ID: 19504849
[No Abstract] [Full Text] [Related]
37. [Editorial: hypertensiology].
Hitzenberger G
Wien Med Wochenschr; 2008; 158(13-14):357-8. PubMed ID: 18677584
[No Abstract] [Full Text] [Related]
38. Should patients with benign prostatic hypertrophy stop taking doxazosin in the light of the ALLHAT study?
Cheng TO
Int J Cardiol; 2006 Feb; 107(2):275-6. PubMed ID: 16412808
[No Abstract] [Full Text] [Related]
39. Diuretics: drugs of choice for the initial management of patients with hypertension.
Fuchs FD
Expert Rev Cardiovasc Ther; 2003 May; 1(1):35-41. PubMed ID: 15030295
[TBL] [Abstract][Full Text] [Related]
40. The ALLHAT-LLT and ASCOT-LLA trials: are the discrepancies more apparent than real?
Hennekens CH
Curr Atheroscler Rep; 2004 Jan; 6(1):9-11. PubMed ID: 14662102
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
